-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Deferred State and Local Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q4 2022.
- Estrella Immunopharma, Inc. Deferred State and Local Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
- Estrella Immunopharma, Inc. Deferred State and Local Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $0.000.
- Estrella Immunopharma, Inc. annual Deferred State and Local Income Tax Expense (Benefit) for 2022 was $0.000.
Deferred State and Local Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred State and Local Income Tax Expense (Benefit), Quarterly (USD)